Peptide Receptor Radionuclide Therapy (PRRT)

Gastrointestinal Neuroendocrine Tumors; Definition, Pathogenesis, Types, Causes, TreatmentПодробнее

Somatostatin receptor scintigraphy Or octreotide scan nuclear medicine imaging techniqueПодробнее

Peptide Receptor Radionuclide Therapy ; Definition, How it works, Benefits, ProcedureПодробнее

PRRT Updates and Announcements November 2024Подробнее

Treatment sequencing and decision-making for metastatic NETsПодробнее

PSNM 2024 - Thernostics Beyond PRRT & PSMA - Zaheer ChiraghПодробнее

PSNM 2024 - PRRT's Initial Experience in Northern Pakistan - Sabeen ZiaПодробнее

Verner Morrison syndrome or WDHA syndrome Watery Diarrhea, Hypokalemia, and Achlorhydria or pancreatПодробнее

VIPoma pancreatic neuroendocrine tumors secrete excessive amounts of Vasoactive Intestinal PeptideПодробнее

Second Line & Beyond Treatment for Neuroendocrine Tumors (NETs)Подробнее

Clinical Experience of Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor in Korea ProfПодробнее

LACNETS • Lu177 Dotatate PRRT + M3814 (Peposertib) • Dr. Aman ChauhanПодробнее

Current evidence and Patient Selection for PRRT Prof Shaunak NavalkissoorПодробнее

NUCLEAR MEDICINE AND PRRT- WHAT IS NEW by Heather Jacene, MD, Dana-Farber Cancer InstituteПодробнее

Understanding PRRT : A Breakthrough in Cancer Therapy | AIIMS | New Delhi | India | Nuclear MedicineПодробнее

2024 NETs Patient and Caregiver Education Symposium (Feb 10, 2024)Подробнее

Episode 34 - NET Treatments: Focus on PRRT • Dr. Riham El KhouliПодробнее

Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine TumorsПодробнее

2024 Brisbane NET Patient ForumПодробнее

NCAN NET Patient Conference - Coralville - PRRT Past, Present, Future & Trials - David Bushnell, MDПодробнее